Analysis of changes in the proteome and phosphoproteome according to DNK72 treatment in patient derived glioblastoma cells
Analysis of changes in the proteome and phosphoproteome according to DNK72 treatment in patient derived glioblastoma cells. (A) In the GSEA EnrichmentMap, leucine-rich repeat kinase 2 (LRRK2) protein expression was positively correlated with the cancer and cell cycle pathway, the RNA-processing associated pathway, and the mitochondria-associated pathway. On the other hand, LRRK2 protein expression was negatively correlated with the FGFR/TP53 pathway. (B) The protein pathway analysis showed that treatment of LRRK2-positive 448T cells with DNK72 resulted in a significant decrease in phosphorylation sites involved in various cellular functions, suggesting that LRRK2 may play a role in regulation stemness through multiple pathways. FDR: false discovery rate, NES: normalized enrichment score, CNS: central nervous system
Publication
Suppression of Glioblastoma Stem Cell Potency and Tumor Growth via LRRK2 Inhibition (2024) Saewhan Park, et al. Int J Stem Cells. 2024;17(3). Figure: F5.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | FGFR | FGFR | famplex_relations | FGFR1 | 2260 |
| Homo sapiens | Primates | FGFR | FGFR | famplex_relations | FGFR2 | 2263 |
| Homo sapiens | Primates | FGFR | FGFR | famplex_relations | FGFR3 | 2261 |
| Homo sapiens | Primates | FGFR | FGFR | famplex_relations | FGFR4 | 2264 |
| Homo sapiens | Primates | FGFR | FGFR | famplex_relations | FGFRL1 | 53834 |
| Homo sapiens | Primates | FGFR/TP53 | TP53 | ncbigene_symbol | TP53 | 7157 |
| Homo sapiens | Primates | NES | NES | ncbigene_symbol | NES | 10763 |
| Homo sapiens | Primates | SMA | SMA | ncbigene_synonym | SMN1 | 6606 |
| Homo sapiens | Primates | TEM | TEM | ncbigene_synonym | CYLD | 1540 |
| Homo sapiens | Primates | TEM | TEM | ncbigene_synonym | TNMD | 64102 |
| Homo sapiens | Primates | TEM | TEM | ncbigene_synonym | MFT2 | 100188881 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | KRAS | 3845 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | NRAS | 4893 |
| Homo sapiens | Primates | RHO | RHO | ncbigene_symbol | RHO | 6010 |
| Homo sapiens | Primates | RHO | RHO | ncbigene_synonym | RHOD | 29984 |
| Homo sapiens | Primates | RHO | RHO | famplex_relations | RHOA | 387 |
| Homo sapiens | Primates | RHO | RHO | famplex_relations | RHOB | 388 |
| Homo sapiens | Primates | RHO | RHO | famplex_relations | RHOC | 389 |
| Homo sapiens | Primates | GAL | GAL | ncbigene_symbol | GAL | 51083 |
| Homo sapiens | Primates | GAL | GAL | ncbigene_synonym | GALP | 85569 |
| Homo sapiens | Primates | LRRK2 | LRRK2 | ncbigene_symbol | LRRK2 | 120892 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| NUCLEUS | nucleus | nucleus | chebi:33252 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Cancer | cancer | cancer | DOID:162 |